Long-term treatment of patients with abnormal intravenous glucose tolerance after myocardial infarction.
D002784:Cholesterol / Q000097:blood; D005069:Evaluation Studies as Topic; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005260:Female; D005951:Glucose Tolerance Test; D006801:Humans; D006943:Hyperglycemia / Q000188:drug therapy / Q000209:etiology*; D007003:Hypoglycemia / Q000139:chemically induced; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications*; D010973:Platelet Adhesiveness; D011379:Prognosis; D014044:Tolbutamide / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D014280:Triglycerides / Q000097:blood; D014527:Uric Acid / Q000097:blood
D005230:Fatty Acids, Nonesterified; D014280:Triglycerides; D014527:Uric Acid; D002784:Cholesterol; D014044:Tolbutamide